Shinhan Investment & Securities predicted that first-quarter growth will be noticeable for Kolmar Korea.

영상제작.편집팀 / 기사승인 : 2024-02-29 16:28:50
  • -
  • +
  • 인쇄

 

[알파경제=박병성 기자] 

Shinhan Investment & Securities analyzed on the 28th that Kolmar Korea is actively responding to mid- to low-priced brand orders in Korea in the first quarter. In the meantime, we maintained our target stock price of 77,000 won and investment opinion 'buy'. Kolmar Korea's closing price for the previous trading day was 45,850 won.

Kolmar Korea posted consolidated sales of KRW 551.7 billion in the fourth quarter of last year, up 15% from the previous year, and operating profit of KRW 37.8 billion, up 336% from a year earlier. Considering 3.5 billion won, which is an excess of performance-based allowance, it seems to be a good performance that meets market expectations.

By corporation, Korea grew 31%, China 18%, North America 10%, Yeonwoo 19%, and HK inno.N 4% year-on-year, leading the company's growth. In terms of operating profit, the Korean subsidiary recorded 18.8 billion won and HK Innoen recorded 21.6 billion won.

Kolmar Korea is expected to see significant growth in the first quarter of this year, led by Korean corporations.

 

 

알파경제 영상제작.편집팀 (press@alphabiz.co.kr)

어플

주요기사

정부 ‘약가 제도 개편’ 후폭풍…제약업계 “생존 기반 위협” 거센 반발 : 알파경제TV2026.02.04
대기업 유상증자 확대에 작년 주식발행 55% 급증…CP·단기사채는 27%↑ : 알파경제TV2026.02.04
카카오 노조, Daum 운영사 AXZ 매각 규탄…“고용안정·상생협약 이행하라” : 알파경제TV2026.02.04
김한국 젠틀몬스터, '공짜노동·부당처우' 파문…노동부, 조사 착수 : 알파경제TV2026.02.04
[현장] '외부인 출입제한' 논란 고덕 아르테온, 이번엔 '아파트 계급론' 공분 : 알파경제TV2026.02.04
뉴스댓글 >

건강이 보이는 대표 K Medical 뉴스

HEADLINE

PHOTO

많이 본 기사